• ABOUT JSLTR
• DIRECTORS AND COMMITTEES
• SECRETARIAT AND MEMBERSHIP

• AIMS AND SCOPE
• ONLINE SUBMISSION
• ARTICLE TYPES
• MANUSCRIPT PREPARATION
• EDITORIAL PROCESS
• POST-ACCEPTANCE
  　　AND TECHNICAL INFORMATION
• EDITORIAL POLICIES
• OPEN ACCESS AND COPYRIGHT
• ADVERTISING POLICY
• CONTACT INFORMATION
• ARCHIVES
• EDITORIAL BOARD

OFFICIAL JOURNAL OF THE JSLTR > ARCHIVES > Journal List > Volume 60, Number 1

• Volume 60(2020), No.1 , Released: April, 2020

  ■Original Article

  Hemosiderin deposition in lymph nodes of patients with plasma cell-type Castleman disease

  Yanyan Han, Takuro Igawa, Kyohei Ogino, Asami Nishikori, Yuka Gion, Tadashi Yoshino
  Yasuharu Sato

  ■Case Report

  Indolent T-cell lymphoproliferative disorder of the stomach successfully treated by radiotherapy

  Naoki Takahashi, Kunihiro Tsukasaki, Mika Kohri, Yu Akuzawa, Tsuyoshi Saek
  Daisuke Okamura, Maho Ishikawa, Tomoya Maeda, Nobutaka Kawai, Akira Matsuda
  Eiichi Arai, Shin Arai, Norio Asou

  Methotrexate-associated lymphoproliferative disorder demonstrating composite lymphoma of EBV-negative diffuse large B-cell lymphoma and EBV-positive mucocutaneous ulcer

  Keiichi Moriya, Yara Yukie Kikuti, Joaquim Carreras, Yusuke Kondo, Sawako Shiraiwa
  Naoya Nakamura

  ■Letter to the Editor

  Poor response to daratumumab and carfilzomib in newly diagnosed anaplastic multiple myeloma

  Masuho Saburi, Masao Ogata, Yasuhiro Soga, Yoshiyuki Kondo, Ryo Kurimoto
  Kazuhito Itani, Kazuhiro Kohno, Hiroki Uchida, Toshiyuki Nakayama

  Challenging diagnoses in oral ulcers with large atypical CD30+ cells: EBV-positive mucocutaneous ulcer differentials

  Dominique Fonseca Rodrigues Lacet, Cristiano Claudino Oliveira

  Is There an Entity of Radiation-Induced Chronic Myeloid Leukemia? Report of a Case and Brief Review of the Literature

  Isao Miyoshi, Masakazu Mori, IchiroYamasaki, Masanori Daibata

  ■Conference Case

  Relapsed refractory nodal peripheral T-cell lymphoma with follicular helper T-cell phenotype was initially resistant to pralatrexate and confirmed to be unresponsive to subsequent forodesine, but responded to re-instituted pralatrexate

  Yasunobu Sekiguchi, Mutsumi Wakabayashi, Haruko Takizawa, Hiroko Iizuka, Sakura Sakajiri
  Keiji Sugimoto, Tadaaki Inano, Yasutaka Fukuda, Yasuharu Hamano, Shigeki Tomita
  Hiroshi Izumi, Mitsuo Okubo, Noriko Nakamura, Tomohiro Sawada, Norio Komatsu
  Masaaki Noguchi

  EXPERT’S COMMENT

  Hisakazu Nishimori